Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

GENDRIVAX

Financiado

Cerrado

Genome driven vaccine development for bacterial infections

The aim of the GENDRIVAX (GENome-DRIVen Vaccine) scientific programme is to develop novel prophylactic vaccines against invasive bacterial diseases caused by Salmonella and Neisseria. GENDRIVAX intends to combine the results of re... ver más

31/12/2014

NVGH

2M€

Presupuesto del proyecto: 2M€

Líder del proyecto

GSK VACCINES INSTITUTE FOR GLOBAL HEALTH SRL No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 4 Participantes

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2014-12-31 No tenemos la información de la convocatoria

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

4 Participantes

NVGH

0.00€ | Lider

GRL

N.D. | Participante

SWISS TPH SWISS TROPICAL AND...

N.D. | Participante

Proyectos interesantes

MCF_IIF Blohmke 2012

Medical Technol...

Data Science

222K€ Cerrado

VacPath

Medical Technol...

Data Science

3M€ Cerrado

CAPCAN

Medical Technol...

Data Science

1M€ Cerrado

BAXERNA 2.0

Medical Technol...

Data Science

9M€ Cerrado

EUCLIDS

Medical Technol...

Data Science

17M€ Cerrado

JCI-2009-05824

Medical Technol...

Data Science

101K€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Líder del proyecto

GSK VACCINES INSTITUTE FOR GLOBAL HEALTH SRL No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 2M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto The aim of the GENDRIVAX (GENome-DRIVen Vaccine) scientific programme is to develop novel prophylactic vaccines against invasive bacterial diseases caused by Salmonella and Neisseria. GENDRIVAX intends to combine the results of recent industrial research (novel platform technologies for producing highly affordable outer membrane antigen based vaccines for Gram-negative bacteria) with the detailed knowledge of the biology of Salmonella and Neisseria infections in Africa supplied by the academic partners. The aim is to make and test the revolutionary concept of vaccines that will be pan-specific. This project is based on collaboration between four institutes: 1. Novartis Vaccines Institute for Global Health S.r.l. (NVGH), the industrial partner with a specific mission to develop vaccines for neglected diseases of developing countries. 2. Wellcome Trust Sanger Institute (WTSI), academic institution working in the research areas of genetics. 3. Swiss Tropical Institute (STI), a public non-commercial organisation with the mission of contributing to health development. 4. Kenya Medical Research Institute (KEMRI), the national body responsible for carrying out health science research in Kenya. The four partners have existing links that form the basis for developing an effective working relationship. However, the academic partners and the industrial partner collaborations are at an early stage (NVGH had its inauguration in February 2008). GENDRIVAX comes at an ideal time as it provides a perfect opportunity to bring together academic innovation with industrial expertise through joint training and exchange initiatives. This activity of Industry-Academia cooperation aims at fulfilling the following goals: 1) to harmonise European research programmes, in order to achieve a critical mass on relevant topics; 2) to foster exchange of scientists; 3) to further improve the quality of European vaccine research of relevance for the developing countries.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores